Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Helicobacter Pylori Eradication Rates of Bismuth-containing Quadruple Therapy vs Modified Quadruple Therapy in Korea; Open-label, Randomized Controlled Trial

NCT03665428 is registered in ClinicalTrials.gov with Chuncheon Sacred Heart Hospital as lead sponsor.

NCT NCT03665428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03665428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Helicobacter Pylori Eradication Rates of Bismuth-containing Quadruple Therapy vs Modified Quadruple Therapy in Korea; Open-label, Randomized Controlled Trial
Lead sponsor
Chuncheon Sacred Heart Hospital
Phase
Phase 4
Overall status
Completed
Start date
July 16, 2018
Completion date
December 31, 2019
Enrollment
233 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter pylori infection